| P2093 | author name string | P B Bloland | |
| | L M Barat | |
| P2860 | cites work | Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? | Q34355300 |
| | Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria | Q34414994 |
| | Ivermectin resistance | Q35908222 |
| | Metronidazole and drug resistance. | Q35908236 |
| | Vivax malaria resistant to treatment and prophylaxis with chloroquine | Q36741010 |
| | Primaquine resistance in Plasmodium vivax | Q38950998 |
| | Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand | Q39188543 |
| | Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria | Q39188623 |
| | Mefloquine-resistant falciparum malaria on the Thai-Burmese border | Q39234433 |
| | Systematic review of amodiaquine treatment in uncomplicated malaria | Q39322887 |
| | Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand | Q39370966 |
| | High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania | Q39416558 |
| | Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique | Q39471565 |
| | Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria | Q39517603 |
| | High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. | Q39517612 |
| | Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist | Q39574566 |
| | Epidemiology of drug resistance in malaria | Q39587600 |
| | Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire | Q39599996 |
| | Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax | Q40848176 |
| | Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone | Q40871708 |
| | Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America | Q41929942 |
| | Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age. | Q41931120 |
| | Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria | Q41932205 |
| | Vivax malaria resistant to chloroquine: case reports from Bombay | Q41932222 |
| | Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa | Q41933010 |
| | Development of resistance to chloroquine by Plasmodium vivax in Myanmar | Q41933142 |
| | Current views on the mechanisms of resistance to quinoline-containing drugs inPlasmodium falciparum | Q41933289 |
| | Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. | Q41937668 |
| | Long-term malaria prophylaxis with weekly mefloquine | Q41937874 |
| | Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa | Q41937986 |
| | The epidemiology of drug-resistant malaria. | Q41944260 |
| | Plasmodium vivax resistance to chloroquine? | Q41945108 |
| | Treatment of primaquine-resistant Plasmodium vivax malaria | Q43786744 |
| | Chloroquine-resistant Plasmodium vivax from Indonesia | Q47874121 |
| | Mefloquine resistance in Plasmodium falciparum | Q47990008 |
| | Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination | Q48009282 |
| | Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria | Q48012248 |
| | Cardiac effects of antimalarial treatment with halofantrine | Q48013877 |
| | Short-term in vitro culture of Plasmodium vivax and P. ovale for drug-susceptibility testing. | Q54220000 |
| | Drug resistance and Giardia. | Q54240459 |
| P433 | issue | 4 | |
| P921 | main subject | drug resistance | Q12147416 |
| | malaria | Q12156 |
| P304 | page(s) | 969-987 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | Infectious Disease Clinics of North America | Q15754797 |
| P1476 | title | Drug resistance among malaria and other parasites | |
| P478 | volume | 11 | |